![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/454 | |
A61P 25/18 |
(11) | Number of the document | 2825167 |
(13) | Kind of document | T |
(96) | European patent application number | 13721817.8 |
Date of filing the European patent application | 2013-03-14 | |
(97) | Date of publication of the European application | 2015-01-21 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/031413 |
Date | 2013-03-14 |
(87) | Number | WO 2013/138602 |
Date | 2013-09-19 |
(30) | Number | Date | Country code |
201261610664 P | 2012-03-14 | US |
(72) |
PHADKE, Deepak, US
WOLFGANG, Curt D., US
POLYMEROPOULOS,Mihael H., US
FEENEY, John Joseph, US
BIRZNIEKS, Gunther, US
|
(73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037,
US
|
(54) | AN ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS |
AN ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS |